---
title: "GSP Crop Science Ltd (GSPCROP) — Share Price, Financials & Analysis"
symbol: "GSPCROP"
company: "GSP Crop Science Ltd"
canonical: "https://tapetide.com/stocks/GSPCROP"
isin: "INE713R01022"
nse_symbol: "GSPCROP"
bse_code: "544733"
sector: "Chemicals"
industry: "Pesticides & Agrochemicals"
market_cap_cr: 2208.71
generated_at: "2026-09-13T18:24:14.595Z"
---

# GSP Crop Science Ltd (GSPCROP)

Canonical page: https://tapetide.com/stocks/GSPCROP

## Company

- **NSE Symbol:** GSPCROP
- **BSE Code:** 544733
- **ISIN:** INE713R01022
- **Sector:** Chemicals
- **Industry:** Pesticides & Agrochemicals
- **Macro Sector:** Commodities
- **Stock Type:** EQUITY
- **Listed Since:** 2026-03-24
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** gspcrop.in

## About

Company mejorly focusing on fungiside and insecticide and related pesticide

## Latest Price

- **Price:** ₹471.25
- **Change:** +0.5 (+0.11%)
- **Open:** ₹472
- **Day High:** ₹485.4
- **Day Low:** ₹464.95
- **Previous Close:** ₹470.75
- **Volume:** 184008
- **As Of:** 2026-09-11T10:27:23+00:00

## Key Fundamentals

Observed at 2026-09-11T04:35:18.344279Z.

- **Market Cap:** ₹2208.71 Cr
- **Classification:** Microcap
- **P/E (reported):** 22.3
- **P/E (TTM):** 19.73
- **EPS (TTM):** ₹23.89
- **Book Value:** ₹165.88
- **Price to Book:** 2.85
- **Dividend Yield:** 0.21%
- **ROE:** 12.3%
- **ROCE:** 20.16%
- **Debt to Equity:** 0.34
- **Revenue (yearly):** ₹1530.9 Cr
- **Net Income:** ₹94.7 Cr
- **EBITDA:** ₹198.9 Cr
- **52-Week High:** ₹667.95
- **52-Week Low:** ₹328
- **RSI (14):** 24.18

## Key Insights

### Weaknesses

- The company has delivered a poor sales growth of 7.09% over past five years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 56.97% | -71.28% | 235.51% |
| ebitda margin growth | 12.89% | 3.01% | 15.36% | 11.12% |
| net income growth | 34.69% | 16.34% | 67% | 8% |
| revenue growth | -4.13% | 17.66% | 8% | 7% |
| roce | 14.05% | -23.64% | -17.17% | 20.88% |
| roe | 34.37% | -31.74% | 15.1% | -20.29% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 276 | 308 | 377 | 467 | 270 | 402 | 386 |
| Expenses | 273 | 268 | 335 | 374 | 257 | 366 | 343 |
| Operating Profit | 3 | 40 | 42 | 93 | 13 | 36 | 43 |
| OPM % | 1 | 13 | 11 | 20 | 4.9 | 9 | 11 |
| Other Income | 1 | 8 | 3 | 1 | -3 | 9 | 8 |
| Interest | 8 | 8 | 8 | 9 | 10 | 10 | 7 |
| Depreciation | 6 | 7 | 7 | 7 | 8 | 8 | 9 |
| Profit before tax | -11 | 32 | 30 | 78 | -8 | 27 | 35 |
| Tax % | -43 | 32 | 24 | 25 | -22 | 28 | 25 |
| Net Profit | -6 | 22 | 23 | 58 | -6 | 20 | 26 |
| EPS in Rs | -1.49 | 5.81 | 6.02 | 15.2 | -1.38 | 4.4 | 5.67 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 903 | 1077 | 1191 | 1203 | 1152 | 1287 | 1517 | 1526 |
| Expenses | 832 | 949 | 1062 | 1125 | 1028 | 1137 | 1332 | 1341 |
| Operating Profit | 72 | 129 | 129 | 79 | 124 | 150 | 185 | 185 |
| OPM % | 8 | 12 | 11 | 7 | 11 | 12 | 12 | 12 |
| Other Income | 4 | 11 | 14 | 6 | 12 | 14 | 9 | 15 |
| Interest | 25 | 18 | 24 | 37 | 34 | 31 | 37 | 35 |
| Depreciation | 18 | 18 | 20 | 21 | 20 | 23 | 30 | 32 |
| Profit before tax | 34 | 103 | 100 | 27 | 82 | 110 | 127 | 133 |
| Tax % | 36 | 34 | 25 | 21 | 26 | 26 | 26 | — |
| Net Profit | 21 | 68 | 76 | 22 | 61 | 82 | 95 | 99 |
| EPS in Rs | 72.32 | 229.88 | 255.77 | 77.84 | 235.61 | 21.38 | 21.05 | 23.89 |
| Dividend Payout % | 10 | 4 | 4 | 3 | 4 | 4 | 5 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 29 | 29 | 29 | 27 | 26 | 39 | 47 |
| Reserves | 302 | 366 | 439 | 336 | 344 | 411 | 725 |
| Borrowings | 169 | 139 | 320 | 324 | 235 | 297 | 262 |
| Other Liabilities | 242 | 383 | 466 | 444 | 374 | 491 | 513 |
| Total Liabilities | 742 | 918 | 1255 | 1132 | 980 | 1238 | 1547 |
| Fixed Assets | 159 | 161 | 166 | 169 | 177 | 214 | 228 |
| CWIP | 7 | 9 | 11 | 16 | 51 | 50 | 67 |
| Investments | 2 | 0 | 2 | 3 | 8 | 12 | 16 |
| Other Assets | 573 | 747 | 1076 | 945 | 745 | 961 | 1236 |
| Total Assets | 742 | 918 | 1255 | 1132 | 980 | 1238 | 1547 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 80 | 114 | -44 | 104 | 207 | 38 | 59 |
| Cash from Investing Activity | -24 | -19 | -42 | -47 | -19 | -80 | -74 |
| Cash from Financing Activity | -59 | -50 | 157 | -159 | -178 | 30 | 152 |
| Net Cash Flow | -3 | 45 | 71 | -102 | 10 | -12 | 137 |
| Free Cash Flow | 64 | 91 | -93 | 70 | 179 | -34 | -17 |
| CFO/OP | 132 | 112 | -23 | 169 | 180 | 45 | 56 |

### Ratios

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 113 | 99 | 125 | 126 | 103 | 112 | 133 |
| Inventory Days | 119 | 153 | 182 | 155 | 111 | 189 | 146 |
| Days Payable | 113 | 162 | 165 | 156 | 114 | 176 | 158 |
| Cash Conversion Cycle | 120 | 90 | 142 | 125 | 99 | 126 | 121 |
| Working Capital Days | 54 | 51 | 72 | 56 | 39 | 50 | 68 |
| ROCE % | — | 23 | 18 | 8 | 17 | 21 | 19 |

## Shareholding Pattern

### Quarterly

| Category | Dec 2024 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- |
| Promoters | 98.25% | 71.72% | 71.73% |
| FIIs | 0% | 11.54% | 9.19% |
| DIIs | 0% | 2.96% | 0.37% |
| Government | 0% | 0% | 0% |
| Public | 0% | 5.9% | 5.17% |
| Others | 1.75% | 7.87% | 13.54% |
| No. of Shareholders | 50 | 49 | 7876 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 5 / 4 / 10

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 569.86 | Sell |
| EMA (10) | 545.41 | Sell |
| SMA (20) | 590.45 | Sell |
| EMA (20) | 568.09 | Sell |
| SMA (50) | 549.65 | Sell |
| EMA (50) | 548.67 | Sell |
| SMA (100) | 488.92 | Sell |
| EMA (100) | 492.15 | Sell |
| SMA (200) | — | Neutral |
| EMA (200) | — | Neutral |

### Oscillators — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 24.12 | Buy |
| MACD (12,26,9) | -15.19 | Sell |
| Stochastic (14,3,3) | 3.35 | Buy |
| ADX (14) | 47.82 | Buy |
| Williams %R (14) | -96.9 | Buy |
| ATR (14) | 30.95 | High Volatility |
| ROC (12) | -26.73 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 34.57 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-25 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bb9cb4a9-376f-4633-933b-f3cd5fa5ffe7.pdf) |
| 2026-08-24 | [Annual General Meeting FY 2025-26](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8ee70632-b434-4048-a8ca-ee6684320e2c.pdf) |
| 2026-08-24 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=75282335-3090-4ff3-8270-fd0ec695e6d2.pdf) |
| 2026-08-24 | [Letter To The Shareholders-Annual Report FY 2025-26](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02ecc281-2c1a-4412-8f68-1a2cc6be55b3.pdf) |
| 2026-08-21 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e7109571-623b-459a-8751-7167d2837f94.pdf) |
| 2026-08-20 | [Record Date For The Purpose Of Determining The Members Eligible To Receive Dividend For The FY 2025-26](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b6695ee0-4d0c-41b6-b5d4-da6305d344ec.pdf) |
| 2026-08-13 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=28b83f9a-b4fa-4d09-a38b-4085ccc5cbda.pdf) |
| 2026-08-12 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=704b2359-75cb-4598-b4d0-a71308e7f030.pdf) |
| 2026-08-12 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3db37c76-8d02-4c87-ad02-f0622866dff3.pdf) |
| 2026-08-11 | [Board Meeting Outcome for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=68c9964c-d460-477a-9243-8a188aa76858.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-17 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c04dacc-0a63-4fe0-8d8e-4cdb0b6ff285.pdf) |
| 2026-04-20 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3db874df-9153-4d9c-bf67-5fa40dce0113.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9c00f61d-93a1-4db1-a882-486ae1ff837c.pdf) |
| 2026-04-17 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4866d48a-576a-4222-a6e4-be1cfc1c40af.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-11 | [Submission Of Standalone And Consolidated Financial Results Of The Company For Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3c3e9cbb-e62e-4ca5-8c73-01da04ab3d75.pdf) |
| 2026-05-26 | [Audited Standalone And Consolidated Financial Results For The Quarter And Financial Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6749bea2-07ba-4c16-a17c-60b458a3874e.pdf) |
| 2026-04-11 | [Approval Of Unaudited Standalone And Consolidated Results For The Quarter And Nine Months Ended 31St December 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f31e63a-807a-4c85-9450-d55cfde08724.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 30 Mar - Trading window closed Apr 1, 2026 until 48 hours after audited results for quarter/year ended Mar 31, 2026. | [Closure of Trading Window 30 Mar - Trading window closed Apr 1, 2026 until 48 hours after audited results for quarter/year ended Mar 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0002ef3f-8cfb-40b5-a853-a332deba7a86.pdf) |
| 29 Apr - ICRA upgraded GSP Crop Science’s ratings on Rs.516.16 crore facilities on April 29, 2026. | [Announcement under Regulation 30 (LODR)-Credit Rating 29 Apr - ICRA upgraded GSP Crop Science’s ratings on Rs.516.16 crore facilities on April 29, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8df054bf-803e-4383-b48b-4a619a5e9ff4.pdf) |
| 29 Apr - ICRA upgraded GSP Crop Science’s ratings on Rs.516.16 crore facilities on April 29, 2026. | [Announcement under Regulation 30 (LODR)-Credit Rating 29 Apr - ICRA upgraded GSP Crop Science’s ratings on Rs.516.16 crore facilities on April 29, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/8df054bf-803e-4383-b48b-4a619a5e9ff4.pdf) |
| 27 Apr - GSP Crop Science says it is not a Large Corporate; outstanding borrowings were Rs 5.82 crore as of March 31, 2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 27 Apr - GSP Crop Science says it is not a Large Corporate; outstanding borrowings were Rs 5.82 crore as of March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/477edd83-3869-462f-896c-a25df3c75242.pdf) |
| 24 Mar - Trading window closed from Mar 24, 2026 until 48 hours after unaudited Q3/9M Dec 31, 2025 results. | [Closure of Trading Window 24 Mar - Trading window closed from Mar 24, 2026 until 48 hours after unaudited Q3/9M Dec 31, 2025 results.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/47ab2990-126f-4308-a1fb-e84b873d60ef.pdf) |
| 24 Mar - Kamleshbhai D Patel appointed DGM-Legal from May 22, 2023; CS & Compliance Officer from Jan 22, 2024. | [Intimation Under Regulation 6(1) Of SEBI (LODR) Regulations 2015 24 Mar - Kamleshbhai D Patel appointed DGM-Legal from May 22, 2023; CS & Compliance Officer from Jan 22, 2024.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ce4b6769-80c9-487d-834c-460c24d9fb66.pdf) |
| 24 Mar - GSP Crop Science appointed MUFG Intime India Pvt Ltd as Registrar & Share Transfer Agent, effective March 24, 2026. | [Intimation Under Regulation 7(1) Of SEBI (LODR) Regulations 2015 24 Mar - GSP Crop Science appointed MUFG Intime India Pvt Ltd as Registrar & Share Transfer Agent, effective March 24, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/564ac4da-e73f-409a-acc0-9635398815d9.pdf) |
| 24 Mar - Filed Code for Fair Disclosure/Insider Trading (Reg 8(2)); available at www.gspcrop.in; dated 24-Mar-2026. | [Announcement Under Regulation 30 (LODR)-Code Of Conduct Under SEBI (PIT) Regulations 2015 24 Mar - Filed Code for Fair Disclosure/Insider Trading (Reg 8(2)); available at www.gspcrop.in; dated 24-Mar-2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/18de4359-8eaf-426a-982b-a5f0ab8d9fc5.pdf) |
| 1d - Board meeting on April 11, 2026 to approve Q3 and nine-month unaudited results. | [Board Meeting Intimation for BOARD MEETING INTIMATION FOR APPROVAL OF UNAUDITED STANDALONE AND CONSOLIDATED FINANCIAL RESULTS FOR THIRD QUARTER AND NINE MONTHS ENDED ON 31 DECEMBER 2025 1d - Board meeting on April 11, 2026 to approve Q3 and nine-month unaudited results.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/f1881dc6-76ef-440a-a922-abffa6058d58.pdf) |
| 1d - Board approved Q3 and nine-month results and 66,740.60 sq m land sale to Indo GSP Chemicals for ₹2,365 lakh. | [Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday April 11 2026 For Approval Of Unaudited Standalone And Consolidated Results For Quarter And Nine Months Ended December 31 2025 1d - Board approved Q3 and nine-month results and 66,740.60 sq m land sale to Indo GSP Chemicals for ₹2,365 lakh.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/549ab4ec-c1a7-4d69-98cc-9b510410608a.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Apr 2026 | [Concall - Apr 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/4866d48a-576a-4222-a6e4-be1cfc1c40af.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:24:14.595Z.